CHRISTIAN MANCILLA: Open Payments
NPI 1568080851 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,264 in 111 payments from 34 companies in 2025. Trend: 2023 $2,594 · 2024 $1,349 · 2025 $3,264
Food & beverage: $2,874Education: $390
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 16 | $353 |
| Incyte Corporation | 4 | $235 |
| Karyopharm Therapeutics Inc. | 7 | $230 |
| Janssen Biotech, Inc. | 8 | $196 |
| Celgene Corporation | 12 | $162 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| E.R. Squibb & Sons, L.L.C. | 2 | $144 |
| AstraZeneca Pharmaceuticals LP | 2 | $143 |
| Medtronic, Inc. | 1 | $130 |
| Pharmacosmos Therapeutics Inc. | 1 | $125 |
Products named: Enhertu, REBLOZYL, XPOVIO, MONJUVI, DATROWAY, OSTEOCOOL RF ABLATION SYSTEM, MONOFERRIC, Vonjo.
Industry payments across TX — which companies pay providers there.
